Synonym | ABT-263-piperazine |
Common Use | Navitoclax-piperazine (ABT-263-piperazine) is a B-cell lymphoma extra large (BCL-XL) inhibitor. Navitoclax-piperazine and a VHL ligand for the E3 ubiquitin ligase can be used in the synthesis of PROTAC DT2216 (HY-130604). |
Structure | |
Purity | 0.9921 |
Storage | • Powder: -20°C 3 years; 4°C 2 years • In solvent: -80°C 6 months; -20°C 1 month |
Molecular Weight | 973.63 |
Molecular Formula | C47H56ClF3N6O5S3 |
CAS No. | 2143096-93-7 |
Appearance | Solid |
Solubility | DMSO: 125 mg/mL (128.39 mM) |
Catalog: CDMDC52
Catalog: CDMDC21
Catalog: CDMDC23
Catalog: CDMDC26
Catalog: CDMDC30
Catalog: CDMDC72
Catalog: CDMDC29
Catalog: CDMDC20
1. Download the template.
2. Enter product information on the template (maximum number of products: 200).
3. Load the file using selector below.
1. Download the template.
2. Enter product information on the template (maximum number of products: 200).
3. Load the file using selector below.